ArticleBritish journal of cancer2015

Prognostic importance of CDK4/6-specific activity as a predictive marker for recurrence in patients with endometrial cancer, with or without adjuvant chemotherapy.

Yuji Ikeda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.